MedTrace Logo

Stem Cells Treatment for Extremely Complex Fistulae (HULPCIR)

NCT01586715 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-04-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the practicability of the autologous e-ASC (Autologous Stem Cells) for the treatment of extremely complex and treatment resistant perianal fistulae.

Conditions

  • Extremely Complex Perianal Fistulae

Interventions

DRUG

Adipose-derived stem cells without expanded

Administration will be intralesional injection of cells suspension. They will be placed into fistula walls

Sponsors & Collaborators

  • Instituto de Investigación Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Damián García Olmo, Prof MD · General Surgery Department (Hospital Universitario La Paz) and Cell Therapy laboratory

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-05-31
Completion
2013-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01586715 on ClinicalTrials.gov